Sen. Bernie Sanders and U.S. Rep. Elijah E. Cummings on Thursday launched an investigation into soaring generic drug prices. “We are conducting an investigation into the recent staggering price increases for generic drugs used to treat everything from common medical conditions to life-threatening illnesses,” Sanders, chairman of a Senate health care subcommittee, and Cummings, ranking member of the House oversight committee, wrote in letters to 14 pharmaceutical companies.
Category Archive: in the news
POST SUMMARY: Not only do patients have to worry about which drug company paid their physician, they need to determine if their generic drug is the same as the branded equivalent and if their insurance company will allow their doctor to write for a specific medication. What is pharma doing to help patients navigate the complex world of empowered patient choices?
POST SUMMARY: At the heart of the FDA’s current social media marketing policy is the failure to understand how patients are using the Internet to make healthcare decisions.
POST SUMMARY: Physicians do not prescribe an Rx because they are getting paid by drug companies. Actually, they are more likely to prescribe a certain product because of insurance companies and managed care incentives.
POST SUMMARY: Digital marketing is moving at warp speed. Pharma companies need to build capabilities in house or ensure that their digital agencies are up to speed to ensure maximum ROI.
POST SUMMARY: Eight out of 10 prescriptions written in the United States are filled with the no-brand name, generic version of the drug prescribed by a doctor. The FDA mandates that generic forms of prescription medication contain the same active ingredient as the brand name, but the agency allows the generic version to use different inactive ingredients, including binders to hold the pill together and time release agents to disperse it.
More Americans surviving cancer than ever. The number of cancer survivors in the U.S. will grow to almost 19 million in 2024, according to a new report from the American Cancer Society. The report says there are currently 14.5 million cancer survivors living in the country.
POST SUMMARY: A strategy to force switch patients into more expensive medication as a branded medication comes off patent is among the dumbest ideas any CEO could put forward.